Search Results - "Kruitwagen, Roy Fpm"

Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure by Konings, Gonda Fj, Saarinen, Niina, Delvoux, Bert, Kooreman, Loes, Koskimies, Pasi, Krakstad, Camilla, Fasmer, Kristine E, Haldorsen, Ingfrid S, Zaffagnini, Amina, Häkkinen, Merja R, Auriola, Seppo, Dubois, Ludwig, Lieuwes, Natasja, Verhaegen, Frank, Schyns, Lotte Ejr, Kruitwagen, Roy Fpm, Xanthoulea, Sofia, Romano, Andrea

“…Endometrial cancer (EC) is the most common gynaecological malignancy in Western society and the majority of cases are estrogen dependent. While endocrine drugs…”
Get full text

A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters by Koeneman, Margot M, MD, van Lint, Freyja HM, MD, van Kuijk, Sander MJ, PhD, Smits, Luc JM, PhD, Kooreman, Loes FS, MD PhD, Kruitwagen, Roy FPM, MD PhD, Kruse, Arnold J, MD PhD

“…This study aims to develop a prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2 (CIN 2) lesions based on simple clinical…”
Get full text

Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer by Zwakman, Nienke, van de Laar, Rafli, Van Gorp, Toon, Zusterzeel, Petra L M, Snijders, Marc P M L, Ferreira, Isabel, Massuger, Leon F A G, Kruitwagen, Roy F P M

“…In patients with advanced stage epithelial ovarian cancer (EOC) the volume of residual tumor after debulking is known as prognostic factor for survival. We…”
Get full text

The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial by van de Poll-Franse, Lonneke V, Nicolaije, Kim A H, Vos, Maria C, Pijnenborg, Johanna M A, Boll, Dorry, Husson, Olga, Ezendam, Nicole P M, Boss, Erik A, Hermans, Ralph H M, Engelhart, Karin C M, Haartsen, Joke E, Pijlman, Brenda M, Feijen, Harrie W H, Mertens, Helena J M M, Nolting, Willem E, van Beek, Johannes J, Roukema, Jan A, Kruitwagen, Roy F P M

“…There is a need for improvement of information provision and post-treatment care for cancer survivors. A Survivorship Care Plan (SCP) is recommended by the…”
Get full text

Sentinel node in ovarian cancer: study protocol for a phase 1 study by Kleppe, Marjolein, Van Gorp, Toon, Slangen, Brigitte F M, Kruse, Arnold J, Brans, Boudewijn, Pooters, Ivo N A, Van de Vijver, Koen K, Kruitwagen, Roy F P M

“…The concept of sentinel lymph node surgery is to determine whether the cancer has spread to the very first lymph node or sentinel node. If the sentinel node…”
Get full text

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial by de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C H W, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, Creutzberg, Carien L, McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan-Willem M., Stam, Tanja C., Van Triest, Baukelien, Van der Steen - Banasik, Elzbieta M., De Winter, Karin A.J., Quinn, Michael A., Kolodziej, Ilka, Pyman, Jan, Johnson, Carol, Capp, Anne, Fossati, Roldano, Gribaudo, Sergio, Lissoni, Andrea A., Ferrero, Annamaria, Artioli, Grazia, Davidson, Cathy, McLachlin, C. Meg, Ghatage, Prafull, Rittenberg, Paula V.C., Souhami, Luis, Thomas, Gillian, Duvillard, Pierre, Berton-Rigaud, Dominique, Tubiana-Mathieu, Nicole

“…Although women with endometrial cancer generally have a favourable prognosis, those with high-risk disease features are at increased risk of recurrence. The…”
Get full text

Understanding Lymphatic Drainage Pathways of the Ovaries to Predict Sites for Sentinel Nodes in Ovarian Cancer by Kleppe, Marjolein, Kraima, Anne C, Kruitwagen, Roy F P M, Van Gorp, Toon, Smit, Noeska N, van Munsteren, Jacoba C, DeRuiter, Marco C

“…In ovarian cancer, detection of sentinel nodes is an upcoming procedure. Perioperative determination of the patient's sentinel node(s) might prevent a radical…”
Get more information

Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2 by Koeneman, Margot M, Hendriks, Natasja, Kooreman, Loes Fs, Winkens, Bjorn, Kruitwagen, Roy Fpm, Kruse, Arnold J

“…Since the implementation of human papillomavirus (HPV)-based screening for cervical cancer, the majority of cervical intra-epithelial neoplasia grade 2 (CIN2)…”
Get more information

High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer by Cornel, Karlijn M.C., Krakstad, Camilla, Delvoux, Bert, Xanthoulea, Sofia, Jori, Balazs, Bongers, Marlies Y., Konings, Gonda F.J., Kooreman, Loes F.S., Kruitwagen, Roy FPM, Salvesen, Helga B., Romano, Andrea

“…Most endometrial cancers (ECs) are diagnosed at an early stage and have a good prognosis. However, 20–30% develop recurrence and have poor survival…”
Get full text

The detection of sentinel nodes in ovarian cancer: a feasibility study by Kleppe, Marjolein, Brans, Boudewijn, Van Gorp, Toon, Slangen, Brigitte F M, Kruse, Arnold J, Pooters, Ivo N A, Lotz, Maartje G, Van de Vijver, Koen K, Kruitwagen, Roy F P M

“…Few sentinel node (SN) studies in ovarian cancer have been reported, mainly because of the risk of tumor dissemination associated with the injection of tracers…”
Get full text

Blocking 17β‐hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach by Konings, Gonda FJ, Cornel, Karlijn MC, Xanthoulea, Sofia, Delvoux, Bert, Skowron, Margaretha A, Kooreman, Loes, Koskimies, Pasi, Krakstad, Camilla, Salvesen, Helga B, van Kuijk, Kim, Schrooders, Yannick JM, Vooijs, Marc, Groot, Arjan J, Bongers, Marlies Y, Kruitwagen, Roy FPM, Romano, Andrea

“…The enzyme type 1 17β‐hydroxysteroid dehydrogenase (17β‐HSD‐1), responsible for generating active 17β‐estradiol (E2) from low‐active estrone (E1), is…”
Get full text

The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis by Burg, Lara C., Verheijen, Shenna, Bekkers, Ruud L.M., IntHout, Joanna, Holloway, Robert W., Taskin, Salih, Ferguson, Sarah E., Xue, Yu, Ditto, Antonino, Baiocchi, Glauco, Papadia, Andrea, Bogani, Giorgio, Buda, Alessandro, Kruitwagen, Roy F.P.M., Zusterzeel, Petra L.M.

“…OBJECTIVEThe aim of this study was to assess the SLN detection rate in presumed early stage, low- and intermediate-risk endometrial cancers, the incidence of…”
Get full text

Comparison of Intraoperative [gamma]-Probe Imaging and Postoperative SPECT/CT in Detection of Sentinel Nodes Related to the Ovary by Speth, Stéphanie CJM, Kruitwagen, Roy FPM, Kleppe, Marjolein, Pooters, Ivo NA, VanGorp, Toon, Slangen, Brigitte FM, Brans, Boudewijn

“…Tracer injection into ovarian ligaments has been shown to detect sentinel nodes (SNs) in patients with ovarian cancer. To determine the possibility that SNs…”
Get full text

Clinicopathologic predictors of early relapse in advanced epithelial ovarian cancer: development of prediction models using nationwide data by Said, Sherin A., Bretveld, Reini W., Koffijberg, Hendrik, Sonke, Gabe S., Kruitwagen, Roy F.P.M., de Hullu, Joanne A., van Altena, Anne M., Siesling, Sabine, van der Aa, Maaike A.

“…•Early relapse (PFI ≤ 6 months) in advanced EOC is associated with a poor prognosis.•There are no validated biomarkers that can predict early relapse in…”
Get full text

Comparison of Intraoperative γ-Probe Imaging and Postoperative SPECT/CT in Detection of Sentinel Nodes Related to the Ovary by Speth, Stéphanie C J M, Kruitwagen, Roy F P M, Kleppe, Marjolein, Pooters, Ivo N A, Van Gorp, Toon, Slangen, Brigitte F M, Brans, Boudewijn

“…Tracer injection into ovarian ligaments has been shown to detect sentinel nodes (SNs) in patients with ovarian cancer. To determine the possibility that SNs…”
Get full text

Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers by Koeneman, Margot M, Kruitwagen, Roy F P M, Nijman, Hans W, Slangen, Brigitte F M, Van Gorp, Toon, Kruse, Arnold-Jan

“…The natural history of high-grade cervical intraepithelial neoplasia (CIN) is largely unpredictable and current histopathological examination is unable to…”
Get more information

Economic evaluation of an expert examiner and different ultrasound models in the diagnosis of ovarian cancer by Meys, Evelyne M.J., Jeelof, Lara S., Ramaekers, Bram L.T., Dirksen, Carmen D., Kooreman, Loes F.S., Slangen, Brigitte F.M., Kruitwagen, Roy F.P.M., Van Gorp, Toon

“…The Risk of Malignancy Index (RMI) is commonly used to diagnose adnexal masses. The aim of the present study was to determine the cost-effectiveness of the RMI…”
Get full text

Blocking 17[beta]-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach by Konings, Gonda FJ, Cornel, Karlijn MC, Xanthoulea, Sofia, Delvoux, Bert, Skowron, Margaretha A, Kooreman, Loes, Koskimies, Pasi, Krakstad, Camilla, Salvesen, Helga B, van Kuijk, Kim, Schrooders, Yannick JM, Vooijs, Marc, Groot, Arjan J, Bongers, Marlies Y, Kruitwagen, Roy FPM, Romano, Andrea

“…The enzyme type 1 17[beta]-hydroxysteroid dehydrogenase (17[beta]-HSD-1), responsible for generating active 17[beta]-estradiol (E2) from low-active estrone…”
Get full text

Surgery for Recurrent Epithelial Ovarian Cancer in the Netherlands: A Population-Based Cohort Study by van de Laar, Rafli, Kruitwagen, Roy F P M, IntHout, Joanna, Zusterzeel, Petra L M, Van Gorp, Toon, Massuger, Leon F A G

“…The value of secondary cytoreductive surgery (SCS) in patients with recurrent epithelial ovarian cancer is controversial. The aim of this population-based…”
Get more information

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study by van de Laar, Rafli, Zusterzeel, Petra L M, Van Gorp, Toon, Buist, Marrije R, van Driel, Willemien J, Gaarenstroom, Katja N, Arts, Henriette J G, van Huisseling, Johannes C M, Hermans, Ralph H M, Pijnenborg, Johanna M A, Schutter, Eltjo M J, Pelikan, Harold M P, Vollebergh, Jos H A, Engelen, Mirjam J A, Inthout, Joanna, Kruitwagen, Roy F P M, Massuger, Leon F A G

“…Improvement in treatment for patients with recurrent ovarian cancer is needed. Standard therapy in patients with platinum-sensitive recurrent ovarian cancer…”
Get full text